The positive-negative distinction in schizophrenia. Review of natural history validators.
about
The neurodevelopmental impact of prenatal infections at different times of pregnancy: the earlier the worse?The current conceptualization of negative symptoms in schizophreniaSp1 expression is disrupted in schizophrenia; a possible mechanism for the abnormal expression of mitochondrial complex I genes, NDUFV1 and NDUFV2Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysisThe clinical boundaries of posttraumatic stress disorder.The interplay between mitochondrial complex I, dopamine and Sp1 in schizophrenia.Late prenatal immune activation in mice leads to behavioral and neurochemical abnormalities relevant to the negative symptoms of schizophrenia.The effect of five years versus two years of specialised assertive intervention for first episode psychosis - OPUS II: study protocol for a randomized controlled trial.Mitochondrial dysfunction in schizophrenia: a possible linkage to dopamine.Positive and negative symptoms in families with schizophreniaTesting Liddle's three-syndrome model in families with schizophreniaHuman slow wave sleep: a review and appraisal of recent findings, with implications for sleep functions, and psychiatric illness.Association study of BCL9 gene polymorphism rs583583 with schizophrenia and negative symptoms in Japanese population.Neurological soft signs might be endophenotype candidates for patients with deficit syndrome schizophreniaDemographic correlates of attenuated positive psychotic symptomsLongitudinal progression of negative symptoms in schizophrenia: a new look at an old problem.Premorbid adjustment, symptom development and quality of life in first episode psychosis: a systematic review and critical reappraisal.Concordance between chart review and structured interview assessments of schizophrenic symptoms.Platelets: A possible glance into brain biological processes in schizophrenia.Characterization of the deficit syndrome in drug-naive schizophrenia patients: the role of spontaneous movement disorders and neurological soft signs.Early-onset schizophrenia: Symptoms and social class of origin.Oxytocin effects in schizophrenia: Reconciling mixed findings and moving forward.The relationship between anhedonia and positive, negative, and general symptomatology in patients with schizophrenia.Criminal offending and distinguishing features of offenders among persons experiencing a first episode of psychosis.Psychological well-being among individuals with first-episode psychosis.Neglect and hereditary risk: Their relative contribution to schizophrenia with negative symptomatology.Schizophrenia and antipsychotic somatic treatment.Mitochondrial Oxidative Phosphorylation System (OXPHOS) Deficits in Schizophrenia: Possible Interactions with Cellular Processes.Neurobiology of schizophrenia: search for the elusive correlation with symptoms.Reemergence of positive symptoms of schizophrenia during the course of treatment with risperidone.Olfactory learning prevents MK-801-induced psychosis-like behaviour in an animal model of schizophrenia.State-dependent alterations in mitochondrial complex I activity in platelets: a potential peripheral marker for schizophrenia.Sociodemographic and clinical variables as predictors of the diagnostic characteristics of first episodes of schizophrenia.Negative symptoms of psychosis: A life course approach and implications for prevention and treatment.Karolinska Scales of Personality, cognition and psychotic symptoms in patients with schizophrenia and healthy controls.Duration of active psychosis and first-episode psychosis negative symptoms.Predictive value of symptoms for quality of life in first-episode schizophrenia.The relationship between regional cerebral blood flow and the Wisconsin Card Sorting Test in negative schizophrenia.Negative psychotic symptoms and impaired role functioning predict transition outcomes in the at-risk mental state: a latent class cluster analysis study.Symptoms at index admission as predictor for 1-5 year outcome in schizophrenia.
P2860
Q28303485-F2C8B7E3-DADB-4931-9E4C-C28D4799C8FAQ30364829-4D719545-FBE1-44E0-9536-2B26DCE5C99AQ33296977-FFD4EE39-607D-4B1C-A4BC-4435489DA93BQ33675212-A0AD401E-157B-40F6-83E1-EFFC9CD5B13FQ34372486-155C309B-7106-461D-9F20-AEC34F3554E4Q34612231-890B0EEE-B120-4D93-AA7B-7D5BEBB27E89Q34660546-C886DDAC-05B3-4FCF-826B-6E7DC27B4772Q34871518-A37864A9-B502-47CE-AC88-5652924E9249Q35020740-E1C40816-2823-4BCF-BEEC-50B558618862Q35281066-87B402EF-C3DF-41B2-A169-722C9A3F709AQ35281127-99A5BE84-8F53-4F78-813E-69332D6AF029Q35489219-9417767E-5823-4C98-B5BD-8C313099797BQ36192989-C90BEF1E-0865-4C4D-9080-60C95170EB84Q36244260-44D1EBD9-12CD-4F2C-8033-3F58180347C4Q36617938-B3864E24-5BF7-4983-B16F-CF5E2CF39C48Q37010792-233CFEA6-DC96-4B03-A8D9-90688D2E7370Q37032907-3711AF1E-71E7-4757-B10A-38F81B2E4E3FQ37118921-28588236-B637-4A85-9530-C91B17E9D973Q37195343-705FBEB2-A8B1-43F0-A15A-D626DDD81A76Q37451422-E432A8C8-7484-4454-A65C-6A6F1C7CA5E0Q38658579-0864734B-9AEC-42A5-BB49-35B5BA6BD6E7Q38683538-43ADF4F1-4ED2-42D3-B07F-058C3AD9975FQ39255165-A19F067D-9E44-42B9-A8B8-306F1B78BA57Q39789215-968BADA7-20CB-47CC-8699-87E63ACEC848Q39865361-468986A0-3086-47F8-805F-C29075591157Q40026498-FAC0423C-EB15-4B0A-A0A4-8DBE5B0CF551Q41459295-CBE2B8B5-E972-4139-AB50-36889CD209CCQ41927221-1F02DA01-56BF-4969-85A8-AEFA501FA907Q42029744-B8866658-4825-4CD4-B3EC-3E76A1975A34Q42400103-7F4BE3A6-D45D-4188-BEAE-3202750974CAQ43862590-50B7D68D-B11F-4A45-9164-221019A58B63Q44194149-0D63B0D1-3A84-48AE-84A8-BE28125B6BD9Q44473288-7B24C90E-13BB-46C6-B847-C2A7F5F2BAE9Q47587674-77E5D5A1-C6F2-40C2-9D64-D90EA749CC27Q47683336-151FE34C-EF16-4FB3-ACDC-5004CE696CC8Q47687615-637F816E-9374-48D6-AD39-12A1B8A6FF3BQ48442552-73F653BD-9918-475B-B7BD-4CD6DFE81FE3Q48641847-A025D674-4DB0-4A06-A01B-E4592F07AEB5Q50535532-6DEF7E95-601E-4D3D-AD66-B9B44CBF8597Q51109357-1697D60C-7D5D-4BBD-9408-14360CAD3776
P2860
The positive-negative distinction in schizophrenia. Review of natural history validators.
description
1992 nî lūn-bûn
@nan
1992年の論文
@ja
1992年論文
@yue
1992年論文
@zh-hant
1992年論文
@zh-hk
1992年論文
@zh-mo
1992年論文
@zh-tw
1992年论文
@wuu
1992年论文
@zh
1992年论文
@zh-cn
name
The positive-negative distinction in schizophrenia. Review of natural history validators.
@ast
The positive-negative distinction in schizophrenia. Review of natural history validators.
@en
type
label
The positive-negative distinction in schizophrenia. Review of natural history validators.
@ast
The positive-negative distinction in schizophrenia. Review of natural history validators.
@en
prefLabel
The positive-negative distinction in schizophrenia. Review of natural history validators.
@ast
The positive-negative distinction in schizophrenia. Review of natural history validators.
@en
P1433
P1476
The positive-negative distinction in schizophrenia. Review of natural history validators.
@en
P2093
P356
10.1001/ARCHPSYC.1992.01820010063008
P407
P577
1992-01-01T00:00:00Z